Journal of Clinical Lipidology

Article	Citations
Cholesterol screening and intervention in youth - It's time to move on	92
From the Editors: More Hot Topics in Clinical Lipidology	91
From the editor: Hope and strength in community	88
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit	75
Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia	52
Monocyte/lymphocyte ratio as a risk factor of cardiovascular and all-cause mortality in coronary artery disease with low-density lipoprotein cholesterol levels below 1.4 mmol/L: A large longitudinal m	50
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans	48
Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database	46
Impact of cumulative exposure to a high TG to HDL-C ratio on type 2 diabetes risk in young adults	45
High-intensity statins vs. moderate-intensity statin-ezetimibe combination therapy: A patient centered approach	44
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report	39
Ezetimibe in the management of homozygous familial hypercholesterolaemia	39
Comprehensive analysis of Chinese patients with non-LPL familial chylomicronemia syndrome: Genetic variants, dietary interventions, and clinical insights	35
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia	34
Real-world utilization of bempedoic acid in an academic preventive cardiology practice	32
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance	29
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	29
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes	26
From the editor: A compendium of lipidology progress	26
Mysterious Case of Reduction in HDL Cholesterol in a Patient with B-cell Monocytosis	26
JCL Roundtable. The lipidology team	26
Genetic Architecture and Cardiovascular Risk of Familial Combined Hyperlipidemia	25
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine	24
^Sex Disparities in the Treatment and Outcomes of Familial Hypercholesterolemia	23
*A Novel ABCG8 Variant and Apo(A) Short Isoform Associated with Premature Atherosclerosis and Familial Hypercholesterolemia Phenocopy.	23

†Efficacy and Safety of Bempedoic Acid in Patients with Metabolic Syndrome	22
†Does Cholesterol Screening in Prader Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?	20
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database	20
The NLRP3 inhibitor and Nrf2 Agonist, RRx-001, Ameliorates Non-alcoholic Fatty Liver Disease in Rats	18
Association Between Dietary Fat Content and Serum Lipoprotein(a) Level	18
Racial Difference in Hypertriglyceridemia and Its Impact on Coronary Heart Diseases	18
The Effect of Estrogen and Testosterone on Cholesterol Crystallization	18
† Higher Cardiovascular Event Rates for High-Risk Americans Who Did Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds	17
† The Vast Majority of High- and Very-High Risk Hypercholesterolemia Patients Never Reach below LDL-C Thresholds in the 2018 ACC/AHA Guidelines	17
Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia	17
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse	17
Treatment Target Achievement in Patients with Familial Hypercholesterolemia: A Real-World Descriptive Study	17
† Survival into the Eleventh Decade in Persons Receiving Statin Therapy	16
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease	16
Patients with Dyslipidemia and Heart Failure Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study	16
Familial LCAT (Lecithin: Cholesterol Acyltransferase) Deficiency: A Case Report	16
The Outcome of Percutaneous Coronary Intervention in Patients with Familial Hypercholesterolemia: A Nationwide Analysis	15
Usefulness of the ApoB Quick Diagnosis App in the Diagnosis of Suspected Familial Chylomicronemia Syndrome	15
Atrial Fibrillation Outcome in Patients with Familiar Hypercholesterolemia	15
† Investigating Hepatocyte Cholesterol Uptake Ex Vivo Following CSL112 (Apolipoprotein A-I [Human]) Infusion in Post Myocardial Infarction Patients	14
Medications Are Not Enough: Interdisciplinary Treatment of Familial Chylomicronemia Syndrome in Pregnancy	14
Genetic Variants in Patients with Persistent, Severe Hypertriglyceridemia	14
LP-PLA2 is more Effective at Predicting Elevated CV Risk in Law Enforcement Officers as Compared to Framingham Risk or Coronary Calcium Scoring	13
Using Virtual Reality and Other Immersive Tools to increase HCPs Ability to Differentially Diagnose and Manage FH	13
Patients with Familial Hypercholesterolemia with Non-Alcoholic Fatty Liver Disease Have Worse Clinical Outcomes, Nation-Wide Study	13
Evinacumab Markedly Reduces Low-density Lipoprotein Cholesterol in Adolescent Patients With Homozygous Familial Hypercholesterolemia†	12
Long-Term Efficacy and Safety of Twice-Yearly Inclisiran in Patients with ASCVD and Elevated LDL-C: A Post-Hoc Analysis of ORION-3, a 4-year Open-Label Extension Study	12
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice	12
Clinical and Economic Impact of Early Rreatment Initiation with Evolocumab in Patients with a Recent Myocardial Infarction in the United States	12
Moderate Alcohol Consumption and Lipoprotein Subfractions: A Systematic Review of Intervention and Observational Studies	12
† Triglyceride Patterns among Patients in US Clinical Practice	12
The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States	11
Editorial Board	11
News from NLA- Jan-Feb 2022	11
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss	11
Hypertriglyceridemia is associated with better outcomes in patients hospitalized for ischemic stroke.	11
Genomic study of maternal lipid traits in early pregnancy concurs with four known adult lipid loci	10
The Dyslipidemia Paradox in Patients Hospitalized for Heart Failure	10
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers	10
Carotid sheath xanthoma: A rare manifestation of lipid disorders	10
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020	10
Editorial Board	10
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State	10
From the editor: Trust and the value paradox in science	10
Statin therapy for primary prevention in men: What is the role for coronary artery calcium?	10
Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort	10
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results	10
JCL Roundtable: Global Think Tank on Lipoprotein(a)	10
Clinical Outcomes And Mortality in Heart Failure And Chronic Kidney Disease Patients Admitted With Non-Variceal Upper Gastrointestinal Bleeding	9
News from NLA	9

Management of diabetic dyslipidemia in South Asian patients: The need for individualized treatment guidelines.	9
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System	9
ASCVD Risk Stratification in a Large Urban Clinic – Role of CACS in Reclassifying Black versus White Individuals Seen for Preventive Care.	9
Editorial Board	9
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis	9
Comparison of Package Insert versus Real World Safety Data from Branded Icosapent Ethyl Users: A Select Analysis Utilizing MarketScan Data	9
From the Editors: Inhibition of cholesteryl ester transfer protein (CETP): Still a promising therapeutic strategy?	9
In memoriam, Avedis Khachadurian 1926 - Sept 22,2022	9
Novel 327bp Alu element insertion in LDLR exon 17 causes alternative splicing and familial hypercholesterolemia	8
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis	8
Negative LDL-C levels with Detectable Apolipoprotein B: Surrogate Markers of Atherosclerotic Disease and Cardiac Event Risk	8
†Assessment of Unmet Clinical Needs and Healthcare Resource Use among Statin-Treated Patients with or at Risk of Developing ASCVD	8
Disparities in access to pharmacotherapies for weight loss and cardiovascular prevention	8
Rapid lipid-lowering response in two cases of autosomal recessive hypercholesterolemia	8
†Role of Epigenetic Regulation and Sp1 Rranscription Factor on DP1 Receptor Expression in Osteoarthritis	8
†The Role of Structured Inpatient Lipid Protocols in Optimizing Non-Statin Lipid Lowering Therapy: A Review and Single-Center Experience	8
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	8
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels	8
A Controlled Intervention Restricting AGEs Improves Carboxymethyl Lysine, RAGE, Lipid, and Inflammatory Indices in Patients Undergoing Hemodialysis	8
The Food Compass Score is Negatively Related to the Activity of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Healthy Adults.	8
+Racial Inequities in Coronary Artery Calcium Screening and Follow-up	8
Utilizing innovative implementation strategies for familial hypercholesterolemia: Correspondence	7
Lipoprotein subfractions and carotid plaque: NMR analysis of triglyceride-rich vs LDL particle size concentrations (ELSA-Brasil study)	7
Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - an observational study	7
Malar rash and hand tremor in early symptoms of cerebrotendinous xanthomatosis and the effect of chenodeoxycholic acid on them	7
High-density lipoprotein infusion therapy: A review	7
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	7
Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease	7
Substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil	7
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease	7
HDL proteome remodeling associates with COVID-19 severity	7
Lipoprotein(a) and High-Density Lipoprotein – A Tale of Two Cities?	7
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia	7
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection	6
Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study	6
Egg consumption induces changes in clinical leukocyte markers that are dependent on sex and baseline white blood cell counts	6
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia	6
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice	6
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic	6
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience	6
Eicosapentaenoic acid Reduces Expression of Pulmonary Endothelial Angiotensin Converting Enzyme (ACE) Linked to Inflammation	6
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis	6
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States	6
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population	6
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma	6
A New Epoch in Treating Diseases of the Heart	6
Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial	6
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia	5
A stepwise approach to prescribing novel lipid-lowering medications	5
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived	5
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	5
Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors	5
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome	5
Direct LDL-C estimation in preschoolers: Practicable first step for FH screening	5
Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease	5
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	5
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial	5
Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy	5
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	5
Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipid	5
Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation	5
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial	5
Epidemiology and longitudinal course of chylomicronemia: Insights from NHANES and a large health care system	4
Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort	4
Use of lipid-lowering therapies in patients with CKD and ASCVD: A 1-year update from GOULD	4
Non-high-density lipoprotein cholesterol outperforms low-density lipoprotein cholesterol in predicting cardiovascular events among high-risk Asians	4
JCL roundtable: Evolution of preventive cardiology and clinical lipidology	4
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy	4
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis	4
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table	4
Successful pregnancy outcome in a woman with cholesteryl ester storage disease treated with enzyme replacement therapy	4
Editorial Board	4
Editorial Board	4
A case of lipoprotein glomerulopathy due to the pathogenic APOE Las Vegas variant c.509C > A: p. (Ala170Asp)	4
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019	4
Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals	4
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects	4
Metabolic Syndrome in Youth - Rite of Passage or Cause for Concern?	4
Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia	4
Pathogenic Intron Variant Familial Hypercholesterolemia: An Atypical Presentation	4

Statin prescribing for primary prevention among people living with HIV	4
Evidence regarding SGLT2 inhibitors for the management of diabetic dyslipidemia	4
Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease	4
Different Manifestations of Familial Hypercholesterolemia in a Mother and Daughter Due to Differing Lipoprotein(a) Levels	4
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association	4
Improving cholesterol management in high-risk primary prevention patients: An evidence-based case series	4
Table of Contents	3
Development of the Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Implementation Toolkit	3
Impact of Non-Alcoholic Fatty Liver Disease on Heart Failure Hospitalizations: Insights from the National Inpatient Sample Database	3
Lipid Biomarkers Associated with Mortality in COVID-19	3
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17-year period	3
Cholesterol trajectories and its relationship with viral load in HIV patients over time	3
The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: A prospective cohort	3
Racial Variations in SGLT2 Inhibitor Prescriptions	3
†High Rates of Cardiovascular Events in Patients with Multivessel Disease in the First Year Post-Myocardial Infarction: A Systematic Literature Review	3
Oleocanthal-Rich Olive Oil's Effect on Postprandial Platelet Activity and Oxidative Stress Markers of Type 2 Diabetic Patients	3
Novel APOB mutation in familial hypobetalipoproteinemia	3
Lipid profile and risk factors for neoatherosclerosis after drug-eluting stent implantation in acute coronary syndrome	3
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors: identification of a new class of small molecules	3
Lipid lowering Injectable Clinic-Novel Idea for Improving Compliance with Twice Yearly Dosing of Inclisiran	3
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results	3
Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia	3
Identification of High Cardiovascular Disease Risk Individuals in an Underserved Patient Population Clinic	3
The recognition and appreciation of Familial Hypercholesterolemia among Internal Medicine residents in the United States	3
*Real-World Experience with Inclisiran at a Large Academic Lipid Clinic	3
News from NLA_May/June 2022	3
Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study	3
Clinical Outcomes in Patients admitted with Diabetes Mellitus and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease	3
Letter regarding the article Sex-Related Differences in Premature Cardiovascular Disease in Familial Hypercholesterolemia	3
Editorial Board	3
Population Analysis of Patients at a Multidisciplinary Prevention Center: Insights, Gaps, and Opportunities	3
†Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-human Primates	3
Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania Health System	3
A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease	3
Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study	3
Association between changes in high-density lipoprotein cholesterol and risk of cardiovascular disease	3
Table of Contents	3
+Differences in Clinical Outcomes between Non-Obese Caucasian and Hispanic Populations Who have Hyperlipidemia	3
Detailed Family History of Premature Atherosclerotic Cardiovascular Disease to Guide Lipoprotein(a) Testing: The Multi-Ethnic Study of Atherosclerosis	3
A Rare Encounter: Familial Lipoprotein Lipase Deficiency in Pregnancy - Case Review and Emerging Therapies for Familial Chylomicronemia Syndrome	3
News from NLA December 2021	3
Clinical Vignette - Keto Diet-Induced Dyslipidemia and Lean Mass Hyper-Responders	2
Severe Hypertriglyceridemia as a Cause of Arterial Thrombosis with Peripheral Embolic Complications.	2
Statins and the Risk of Breast, Lung, Colorectal, and Prostate Cancers	2
Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece	2
The Healthy Eating Assessment Tool (HEAT): A Aimplified 10-Point Assessment of CHILD-2 Dietary Compliance for Children with Dyslipidemia	2
*Achievement of Low-Density Lipoprotein Cholesterol (LDL-C) Thresholds in Patients with Very High-Risk Atherosclerotic Cardiovascular Disease (ASCVD)	2
Diagnosis and Management of Familial Dysbetalipoproteinemia in a Patient with Apo E2/E2 Genotype	2
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols	2
† Pegozafermin for the Treatment of Severe Hypertriglyceridemia, a Randomized, Double-blind, Placebo-controlled Phase 2 Trial (ENTRIGUE STUDY)	2
News from the NLA	2
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center	2
Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua	2
From the Editors: Familial hypercholesterolemia: Still underdiagnosed and undertreated	2
Pegylated-Asparaginase Induced Severe Hypertriglyceridemia in an Adult with Acute B-cell Lymphoblastic Leukemia	2
Comparing Prescribing Practices of Statin Therapy in Atherosclerotic Cardiovascular Disease Patients with Varying Levels of Chronic Kidney Disease	2
A Rare Dyslipidemia: Review of Diagnosis and Therapeutics in Management of Familial Chylomicronemia Syndrome (FCS)	2
Unveiling Compound Heterozygous Familial Hypercholesterolemia	2
Unique Case of Management of Severe Hypertriglyceridemia Secondary to Familial Chylomicronemia Syndrome	2
Management of Dyslipidemia in a Patient with Cerebral Cavernoma	2
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk	2
Direct Contact of At-Risk Relatives in the United States Identifies Familial Hypercholesterolemia Cases	2
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten	2
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI	2
Editorial Board	2
Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study	2
Characterization of Inclisiran Use in Real World: Prescription Data from Germany	2
A Complex Case: Patient with Elevated Lp(a) and Debilitating Stroke	2
CME Activity Highlights the Improvement in Clinician's Knowledge and Competence about Treatment Choices for LDL-C Lowering Post-MI	2
Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece	2
Timing of PCSK9i Initiation and Its Relationship with Clinical Outcomes in US Patients with Prior Cardiovascular Events: A Claims Database Analysis	2
Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands	2
⁎ Incidental Coronary Calcium on Non-Gated CT Scans of the Chest: A Stepwise Approach to Addressing Underreporting and Implementing Deep Learning	2
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study	2
*! Very-High-Risk Atherosclerotic Cardiovascular Disease Status Among Patients with CAC >1000: Implications for Intensive Lipid-Lowering Therapy	2
Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia	2
Table of Contents	2
Table of Contents	2
A Randomized Study to Evaluate the Effect of an Inclisiran First Implementation Strategy vs Usual Care in Patients with ASCVD and Elevated Low-density Lipoprotein Cholesterol: Rationale and Design of	2